[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
June 4, 2008

Radiopharmaceutical Reimbursement Rates

JAMA. 2008;299(21):2512-2513. doi:10.1001/jama.299.21.2512-c

To the Editor: In her Medical News & Perspectives article, Dr Hampton1 stated, “Medicare reimbursement for radioimmunotherapy was recently cut, and Medicare payments will fall $10 000 short of the cost for each patient treated. . . . ” Although the Centers for Medicare & Medicaid Services (CMS) reduced payment for radioimmunotherapeutics in its final reimbursement rulings for 2008, Congress reversed the CMS ruling. It mandated through the Medicare, Medicaid, and SCHIP Extension Act of 2007 that radiopharmaceutical reimbursement rates be kept at current (2007) levels through the first half of 2008.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×